[Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection]. [electronic resource]
Producer: 20171204Description: 199-201 p. digitalISSN:- 1578-8989
- Adult
- Amoxicillin -- therapeutic use
- Antacids -- therapeutic use
- Anti-Bacterial Agents -- therapeutic use
- Bismuth -- therapeutic use
- Clarithromycin -- therapeutic use
- Drug Therapy, Combination
- Female
- Helicobacter Infections -- drug therapy
- Helicobacter pylori
- Humans
- Male
- Metronidazole -- therapeutic use
- Middle Aged
- Proton Pump Inhibitors -- therapeutic use
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.